News

Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release

Biotech gets hot in July August 02, 2010 | Press Release

Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


International

Michael Keyoung, MD, PhD

Managing Director, Burrill Pan-Asia

Korea, Greater China

Dr. Keyoung has more than 15 years of healthcare and life science experience through his role as scientist, surgeon, consultant and investor. At Burrill & Company, Dr. Keyoung manages Burrill’s Pan-Asia/Korea Private Equity Fund, oversees Burrill’s US and European public portfolio companies and leads our Pan-Asia transaction business as well as our global arbitrage efforts across multiple countries in Asia. Previously, Dr. Keyoung was a co-founder of a life science healthcare investment partnership in New York. Dr. Keyoung also served as an advisor and consultant leading life sciences venture capital firms, medical devices, pharma, and biotechnology companies.  Previously, Dr. Keyoung was a Howard Hughes Medical Institute fellow and received his clinical surgical training at University of California, San Francisco and biomedical fellowship at Memorial Sloan Kettering Institute and Rockefeller University in New York. Dr. Keyoung performed preclinical drug discovery research for Aventis (now Sanofi-Aventis) and Merck while at Cornell and participated in cutting-edge translational clinical trials at leading academic centers. As National Institute of Health-Medical Scientist Training Program scholarship recipient, Dr. Keyoung received both his Medical Doctorate and Doctor of Philosophy degrees in Neuroscience and Neurology from Cornell University Weill Medical College and Memorial Sloan Kettering Cancer Center. Dr. Keyoung has over 35 articles, book chapters and presentations in publications such as Nature Biotechnology and Nature Medicine.     

Dr. Keyoung currently serves as an advisory board member to Korea Evaluation Institute of Industrial Technology (KEIT) under the auspice of Ministry of Knowledge Economy of Korean Government. KEIT is a government-run agency that manages Korean national R&D programs and implements government innovation policies with a current budget of $10 billion. Dr. Keyoung has served on the Board of Overseers at the Cornell University-Weill Medical College in New York and New York County Medical Board of Directors and currently serves on the boards of other companies and organizations in the U.S. and in Asia.